consultations through work placements
Dr Petraitienė provides consultations on the diagnosis and treatment of precancerous breast diseases, hormone replacement therapy. Carries out various breast mass removal surgeries.
She trained at the Moabit Hospital in Berlin, Germany, and at the Minsk Institute of Oncology and Radiology in Belarus. She has prepared more than ten different scientific publications and has had reports published in scientific medical journals. She has also presented papers at conferences. In 2018, she won the Golden Doctor's Heart Award.
Patients about doctor
1966–1972 – internship of surgery at Therapeutic Faculty of Kaunas University of Medicine.
1972–1973 doctor surgeon–intern at Department of Surgery of Kaunas 2nd Clinical Hospital.
2003 – defended PhD thesis “Hormone Replacement Therapy and Fibrocystic Breast Disease”.
From 2005–onwards Dr breast oncosurgeon at JSC “SK Impeks Medical Diagnostic and Treatment Center”.
2002–2005 Dr breast oncosurgeon at Consulting clinic of Vilnius University Oncology Institute.
1990–2002 Dr breast oncosurgeon at Consulting clinic of Lithuanian Oncology Center (currently Vilnius University Oncology Institute).
1989–1990 head physician–doctor oncosurgeon at the Clinic under Lithuanian Institute of Oncology (currently Institute of Oncology of Vilnius University).
1982–1989 deputy head physician for clinical affairs–doctor oncosurgeon at the Clinic under Lithuanian Institute of Oncology.
1978–1982 doctor oncosurgeon at Thoracic surgery department of Lithuanian Institute of Oncology.
1976–1978 clinical residency in oncological surgery at Lithuanian Institute of Oncology.
1973–1976 doctor surgeon at Department of Surgery of Kaunas 2nd Clinical Hospital.
Oncologist (obtained the highest category in 1996).
2000 – 1 month, “General Oncology” at Lithuanian Oncology Center, Vilnius, Lithuania.
1999 – 1 month, “Ultrasonic research in gynaecology” at Lithuanian Oncology Center, Vilnius, Lithuania.
1993 – 1 month “Oncology and Breast Surgery” at Moabit Hospital in Berlin, Germany.
1978 – 5 months of placement for oncologist–surgeon at Research Institute of Oncology and Medical Radiology in Minsk, Belarus.
2001 – a member of the international conference “Hormone Replacement Therapy” in Riga, Latvia.
2008 – author of the chapter “Benign Breast Diseases” in the book “Practical Guide of Obstetrics and Gynaecology”.
2006 – “Oral Hormonal Contraceptives and the Risk of Breast Cancer” meeting of Vilnius Society of Obstetricians and Gynaecologists and conferences of Klaipėda and Šiauliai Society of Obstetricians and Gynaecologists.
2005 – “Oral Hormonal Contraceptives and the Risk of Breast Cancer” conference of Kaunas Society of Obstetricians and Gynaecologists, Lithuania.
2003 – “Hormone Replacement Therapy and Fibrocystic Breast Disease” conference of Panevėžys Obstetricians and Gynaecologists, Lithuania.
2003 – “Hormone Replacement Therapy and Fibrocystic Breast Disease” conference of ultrasonic research in Palanga, Lithuania.
2002 – “Influence of Oral Hormonal Contraceptives on Fibrocystic Breast Disease“ conference for the oncologists from the Baltic States in Vilnius, Lithuania.
1997 – “Pre-cancerous breast diseases and breast cancer is a consequence of hormonal disorders”, “Pre-cancerous breast diseases, breast cancer and hormones” scientific and practical conference in Vilnius.
2003 – article “Reproduction Factors in Women and Cystic Fibrotic Disease of Breasts (Mastopathy)” in journal “Acta Medicina Lithuania”.
2002 – “Influence of Hormone Replacement Therapy on Benign Breast Diseases”, “Influence of Combined Oral Contraceptives on Mastopathy” in publication “Lithuanian endocrinology”.
There are many other articles about pre-cancerous breast diseases, hormonal contraception, hormone replacement therapy, early diagnostics of breast cancer in scientific journals.
Membership in professional and public organisations:
From 1978 – a member of Scientific Society of Oncology.
From 2002 – a member of Society of Gynaecology.
From 1978 Vida provides consultations and performs outpatient surgeries for women with pre-tumorous breast diseases.
From 1995 she is interested in the influence of hormone replacement therapy and oral hormonal contraceptives on fibrocystic breast disease and other pre-tumorous breast diseases.